Hu Hu

3.4k total citations
71 papers, 2.4k citations indexed

About

Hu Hu is a scholar working on Molecular Biology, Hematology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Hu Hu has authored 71 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 19 papers in Hematology and 14 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Hu Hu's work include Platelet Disorders and Treatments (18 papers), Antiplatelet Therapy and Cardiovascular Diseases (11 papers) and Analytical Chemistry and Sensors (4 papers). Hu Hu is often cited by papers focused on Platelet Disorders and Treatments (18 papers), Antiplatelet Therapy and Cardiovascular Diseases (11 papers) and Analytical Chemistry and Sensors (4 papers). Hu Hu collaborates with scholars based in China, Sweden and United States. Hu Hu's co-authors include Nailin Li, Paul Hjemdahl, Malin Lindqvist, E. Jönsson, Alison H. Goodall, Hong Ouyang, Lei Jiang, Maode Lai, Dongjiao Luo and Zi Yin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Hu Hu

69 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hu Hu China 30 793 450 381 344 315 71 2.4k
Bruce A. Hug United States 23 1.6k 2.0× 601 1.3× 590 1.5× 339 1.0× 502 1.6× 47 3.6k
Tong Yin China 25 1.1k 1.4× 972 2.2× 379 1.0× 415 1.2× 383 1.2× 102 3.1k
Rongli Zhang China 31 1.7k 2.1× 322 0.7× 307 0.8× 278 0.8× 464 1.5× 132 3.0k
Sinéad Toomey Ireland 19 714 0.9× 301 0.7× 231 0.6× 234 0.7× 187 0.6× 66 2.0k
Peter Ellinghaus Germany 28 1.6k 2.1× 245 0.5× 217 0.6× 519 1.5× 465 1.5× 74 3.1k
Najmaldin Saki Iran 28 1.3k 1.6× 848 1.9× 582 1.5× 234 0.7× 146 0.5× 222 3.2k
Jianchun Chen China 24 937 1.2× 195 0.4× 306 0.8× 238 0.7× 172 0.5× 56 2.4k
Andreas H. Wagner Germany 29 766 1.0× 137 0.3× 708 1.9× 662 1.9× 564 1.8× 97 2.9k
Péter Polgàr United States 29 1.1k 1.3× 183 0.4× 324 0.9× 227 0.7× 339 1.1× 117 2.6k
Nikolaos Kavantzas Greece 30 1.0k 1.3× 128 0.3× 243 0.6× 379 1.1× 205 0.7× 183 2.9k

Countries citing papers authored by Hu Hu

Since Specialization
Citations

This map shows the geographic impact of Hu Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hu Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hu Hu more than expected).

Fields of papers citing papers by Hu Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hu Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hu Hu. The network helps show where Hu Hu may publish in the future.

Co-authorship network of co-authors of Hu Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Hu Hu. A scholar is included among the top collaborators of Hu Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hu Hu. Hu Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Meng, Ying, Saskia Heybrock, Qiang Zhao, et al.. (2025). Sphingosine-1-phosphate signalling activates E-Syt1 to facilitate HDL-derived cholesterol transport. Nature Cell Biology. 27(6). 918–930.
3.
Chen, Cao, Qingyuan Yang, Xiaoshuang Xia, et al.. (2024). WY-14643, a novel antiplatelet and antithrombotic agent targeting the GPIbα receptor. Thrombosis Research. 238. 41–51. 2 indexed citations
4.
Song, Xinghui, Ning He, Yanwei Li, et al.. (2021). A Novel Age-Related Circular RNA Circ-ATXN2 Inhibits Proliferation, Promotes Cell Death and Adipogenesis in Rat Adipose Tissue-Derived Stromal Cells. Frontiers in Genetics. 12. 761926–761926. 7 indexed citations
5.
Hou, Jinchao, Qixing Chen, Xiaoliang Wu, et al.. (2017). S1PR3 Signaling Drives Bacterial Killing and Is Required for Survival in Bacterial Sepsis. American Journal of Respiratory and Critical Care Medicine. 196(12). 1559–1570. 45 indexed citations
6.
Jiang, Ting, Kun Ren, Qian Chen, et al.. (2017). Leonurine Prevents Atherosclerosis Via Promoting the Expression of ABCA1 and ABCG1 in a Pparγ/Lxrα Signaling Pathway-Dependent Manner. Cellular Physiology and Biochemistry. 43(4). 1703–1717. 64 indexed citations
7.
Li, Qiang, Jian Shen, Xiaohui Liu, et al.. (2014). Modulation of Platelet Activation and Thrombus Formation Using a Pan-PI3K Inhibitor S14161. PLoS ONE. 9(8). e102394–e102394. 21 indexed citations
8.
Zhou, Qi, Lei Jiang, Dongjiao Luo, et al.. (2013). Ginsenoside Rg1 inhibits platelet activation and arterial thrombosis. Thrombosis Research. 133(1). 57–65. 64 indexed citations
9.
Hu, Hu. (2013). Clinical effect of shenqifuzheng injection combined with 3DCRT in the treatment of advanced non-small cell lung cancer. 1 indexed citations
10.
Weng, Chunhua, Haojie Dong, Guangdi Chen, et al.. (2012). miR-409-3p inhibits HT1080 cell proliferation, vascularization and metastasis by targeting angiogenin. Cancer Letters. 323(2). 171–179. 56 indexed citations
11.
Gao, Xiangwei, Saisai Wei, Kairan Lai, et al.. (2010). Nucleolar Follistatin Promotes Cancer Cell Survival under Glucose-deprived Conditions through Inhibiting Cellular rRNA Synthesis. Journal of Biological Chemistry. 285(47). 36857–36864. 28 indexed citations
12.
Zhou, Huihui, Hu Hu, & Maode Lai. (2010). Non‐coding RNAs and their epigenetic regulatory mechanisms. Biology of the Cell. 102(12). 645–655. 60 indexed citations
13.
Lü, Bingjian, et al.. (2008). Downregulation of Krüppel‐like factor 9 in human colorectal cancer. Pathology International. 58(6). 334–338. 46 indexed citations
14.
Yang, Yumin, Jun-zhu Chen, Xingxiang Wang, et al.. (2008). Resveratrol attenuates thromboxane A2 receptor agonist-induced platelet activation by reducing phospholipase C activity. European Journal of Pharmacology. 583(1). 148–155. 37 indexed citations
15.
Dong, Zhengwei, Hu Hu, Weijun Chen, et al.. (2007). Heat shock does not induce γH2AX foci formation but protects cells from N-methyl-N′-nitro-N-nitrosoguanidine-induced genotoxicity. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 629(1). 40–48. 12 indexed citations
16.
Ruan, Wenjing, Enping Xu, Fangying Xu, et al.. (2007). IGFBP7 plays a potential tumor suppressor role in colorectal carcinogenesis. Cancer Biology & Therapy. 6(3). 354–359. 87 indexed citations
17.
Qian, Qian, Hu Hu, Lü, et al.. (2006). The derivation of two additional human embryonic stem cell lines from day 3 embryos with low morphological scores. 中国生物学文摘. 20(7). 34–34. 9 indexed citations
18.
Hu, Hu. (2005). Study on effect of docetaxel on proliferation and invasion of human breast cancer cells. 2 indexed citations
19.
Hu, Hu, et al.. (2005). Influence of extracellular calcium on single platelet activation as measured by whole blood flow cytometry. Thrombosis Research. 116(3). 241–247. 20 indexed citations
20.
Hu, Hu, David Varon, Paul Hjemdahl, et al.. (2003). Platelet-leukocyte aggregation under shear stress: Differential involvement of selectins and integrins. Thrombosis and Haemostasis. 90(10). 679–687. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026